However, treatment with the hemichannel inhibitors Gap19 or Gap26 protects DMD mice from arrhythmogenesis and death suggesting that Cx43 hemichannel activity and lateralization are linked with arrhythmia in vivo (207). Here, GJA1 is linked to Duchenne muscular dystrophy.